CTSA Administrative Supplement for Informatics Core: A novel AI/ML system to predict respiratory failure and ARDS in Covid-19 patients
CTSA 信息学核心行政补充:一种预测 Covid-19 患者呼吸衰竭和 ARDS 的新型 AI/ML 系统
基本信息
- 批准号:10158737
- 负责人:
- 金额:$ 100.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-09 至 2021-02-28
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAcuteAcute respiratory failureAddressAdministrative SupplementAdult Respiratory Distress SyndromeArrhythmiaArtificial IntelligenceAwardAwarenessCOVID-19COVID-19 pandemicCessation of lifeClinicalClinical DataClinical Decision Support SystemsClinical ResearchCollaborationsCommunitiesCompetenceComplexCoronavirusDataData ScienceData ScientistDetectionDeteriorationDevelopmentDiagnosisEngineeringExpert SystemsFatal OutcomeFunctional disorderFundingFutureGenerationsGoalsHealthHealth systemHealthcareHeart InjuriesHospitalsHypoxemiaInfectionInformaticsInjury to KidneyInpatientsInstitutesInterventionLeadLifeLinkLiteratureLung ComplianceMechanical ventilationMedical centerMethodsModelingMorbidity - disease rateNew York CityOrganParentsPatientsPneumoniaPopulationPreventiveProcessPublic HealthPublishingResearchResearch PersonnelResearch SupportResourcesRespiratory FailureRisk AssessmentSeasonsSeveritiesSoftware EngineeringSourceStandardizationSystemThromboembolismTimeTrainingTranslatingTranslational ResearchUnited States National Institutes of HealthUpper Respiratory Infectionsbasecare deliverycare providersclinical decision-makingcohortcomplex data coronavirus diseasedata modelingdeep learningdesignevidence baseexperiencefluhealth datainfection rateinnovationmachine learning algorithmmortalitymultidisciplinarynovelpandemic diseasepreemptive interventionpreventprognosticprogramsresponsesoftware systemstool
项目摘要
PROJECT SUMMARY
The Einstein-Montefiore Institute for Clinical and Translational Research (ICTR) proposes an Administrative
Supplement pursuant to NOT-TR-20-011, CTSA Program Applications to Address 2019 Novel Coronavirus
(Covid-19). Specifically, this application addresses the urgent need for research on the coronavirus pandemic
with a project focusing on informatics and data science to preemptively identify patients with the life-
threatening complications of SARS-CoV-2, using CTSA-supported core resources. Characterized by severe
hypoxemia, tachypnea, and decreased lung compliance, the diagnosis of acute respiratory failure (ARF) is a
bad prognostic sign, and in a subset, leads to development of acute respiratory distress syndrome (ARDS).
The rates of Covid-19 infection and death in the Bronx have been higher than any other borough of NYC. As
the major regional health system, our experience with Covid-19 provides guideposts that may prevent future
victims of this pandemic. The bleak picture for ARDS in the 4,452 patients admitted showed that 78% of our
intubated Covid-19 patients developed ARDS, with 42% mortality. The overall goal of this proposal is to
leverage our novel informatics and analytics platforms enabled by the Einstein-Montefiore CTSA (NIH/NCATS
1ULTR002556), and extensive Artificial Intelligence and Deep Learning resources to implement a novel,
situational awareness and clinical decision support system for ARF and ARDS (SA-ARDS). We will re-train our
existing deep learning models with data collected from Covid-19 patients and contextualize its implementation
with data from the Covid-19 response during the pandemic in NYC. The SA-ARDS data platform will provide
longitudinally integrated clinical data for research and multi-institutional and national collaborations, with the
following specific aims: Aim 1: To integrate, re-train, and validate our novel, near real-time, Electronic Risk
Assessment System (ERAS 1.0) optimized for early recognition of ARF, ARDS, and inpatient mortality; Aim 2:
To develop an evidence based, real-time, and context appropriate Situational Awareness clinical decision
support system targeting ARF and ARDS response (SA-ARDS); and Aim 3: Through our partner CTSA
organizations, to standardize and disseminate ERAS 1.0 and the SA-ARDS to other health systems, including
the NYC consortium of CTSA hubs and the PCORI INSIGHT network. We will use the clinical data underlying
the SA-ARDS to support research in local, regional, and national collaborations. All the methods and tools
developed will be shared with the CTSA community via NCATS' National Center for Data to Health (CD2H).
项目概要
爱因斯坦-蒙蒂菲奥里临床和转化研究所 (ICTR) 提出了一项行政管理
根据 NOT-TR-20-011、CTSA 计划申请的补充,以应对 2019 年新型冠状病毒
(新冠肺炎)。具体来说,该应用程序解决了冠状病毒大流行研究的迫切需求
一个专注于信息学和数据科学的项目,旨在抢先识别患有生命危险的患者
使用 CTSA 支持的核心资源,应对 SARS-CoV-2 的威胁性并发症。其特点是严重
低氧血症、呼吸急促和肺顺应性下降,急性呼吸衰竭(ARF)的诊断是
不良的预后征兆,并且在一部分中,会导致急性呼吸窘迫综合征(ARDS)的发展。
布朗克斯区的 Covid-19 感染率和死亡率高于纽约市任何其他行政区。作为
对于主要的区域卫生系统,我们在 Covid-19 方面的经验提供了指导方针,可以预防未来的
这次流行病的受害者。 4,452 名收治的 ARDS 患者的惨淡情况表明,我们 78% 的患者
插管的 Covid-19 患者出现 ARDS,死亡率为 42%。该提案的总体目标是
利用由 Einstein-Montefiore CTSA (NIH/NCATS) 支持的新型信息学和分析平台
1ULTR002556),以及广泛的人工智能和深度学习资源来实施新颖的、
ARF 和 ARDS 的态势感知和临床决策支持系统 (SA-ARDS)。我们将重新训练我们的
现有的深度学习模型,包含从 Covid-19 患者收集的数据,并将其实施情境化
纽约市大流行期间 Covid-19 应对措施的数据。 SA-ARDS数据平台将提供
纵向整合临床数据用于研究以及多机构和国家合作,
以下具体目标: 目标 1:集成、重新训练和验证我们新颖的、近实时的电子风险
评估系统(ERAS 1.0)优化用于早期识别 ARF、ARDS 和住院患者死亡率;目标 2:
制定基于证据的、实时的、适合情境的情境意识临床决策
针对 ARF 和 ARDS 反应的支持系统 (SA-ARDS);目标 3:通过我们的合作伙伴 CTSA
组织,以标准化 ERAS 1.0 和 SA-ARDS 并将其传播到其他卫生系统,包括
纽约市 CTSA 中心联盟和 PCORI INSIGHT 网络。我们将使用基础临床数据
SA-ARDS 支持地方、区域和国家合作的研究。所有方法和工具
开发的数据将通过 NCATS 国家健康数据中心 (CD2H) 与 CTSA 社区共享。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARLA J KELLER其他文献
MARLA J KELLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARLA J KELLER', 18)}}的其他基金
Einstein-Montefiore Clinical and Translational Science Award Hub
爱因斯坦-蒙蒂菲奥里临床和转化科学奖中心
- 批准号:
10622099 - 财政年份:2023
- 资助金额:
$ 100.34万 - 项目类别:
Convalescent Plasma to Limit Coronavirus Associated Complications: A Randomized Blinded Phase 2 Study Comparing the Efficacy and Safety of Anti-SARS-CoV-2 Plasma to Placebo in COVID-19 hospitalized pa
恢复期血浆限制冠状病毒相关并发症:一项随机盲法 2 期研究,比较抗 SARS-CoV-2 血浆与安慰剂在 COVID-19 住院患者中的功效和安全性
- 批准号:
10166008 - 财政年份:2020
- 资助金额:
$ 100.34万 - 项目类别:
Modifies of PrEP Efficacy in US & African Women: Age, Hormones, Sex & Microbiota
美国 PrEP 疗效的修改
- 批准号:
8448509 - 财政年份:2013
- 资助金额:
$ 100.34万 - 项目类别:
Safety of Non-Medicated Intravaginal Rings for Microbicide Delivery
用于杀菌剂递送的非药物阴道环的安全性
- 批准号:
8012508 - 财政年份:2010
- 资助金额:
$ 100.34万 - 项目类别:
Clinical Study to Measure Pharmacokinetics, Pharmacodynamics and Safety of a TDF
测量 TDF 的药代动力学、药效学和安全性的临床研究
- 批准号:
8210597 - 财政年份:2009
- 资助金额:
$ 100.34万 - 项目类别:
EFFECTS OF HORMONES ON MUCOSAL IMMUNE MEDIATORS ACROSS THE MENSTRUAL CYCLE
激素对整个月经周期粘膜免疫介质的影响
- 批准号:
7718170 - 财政年份:2008
- 资助金额:
$ 100.34万 - 项目类别:
EFFECTS OF HORMONES ON MUCOSAL IMMUNE MEDIATORS ACROSS THE MENSTRUAL CYCLE
激素对整个月经周期粘膜免疫介质的影响
- 批准号:
7718170 - 财政年份:2008
- 资助金额:
$ 100.34万 - 项目类别:
相似国自然基金
剪接因子U2AF1突变在急性髓系白血病原发耐药中的机制研究
- 批准号:82370157
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
IKZF1-N159Y/S热点突变在急性白血病中的致病机制研究
- 批准号:82300168
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NMNAT1上调B7-H3介导急性早幼粒细胞白血病免疫逃逸的作用和机制研究
- 批准号:82300169
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支链氨基酸转氨酶1在核心结合因子急性髓细胞白血病中的异常激活与促进白血病发生的分子机制研究
- 批准号:82370178
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
SRSF3/LRP5/Wnt信号通路在急性淋巴细胞白血病中的作用及机制研究
- 批准号:82370128
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Natural model for evaluating within- and cross-species virus transmission
评估物种内和跨物种病毒传播的自然模型
- 批准号:
10735974 - 财政年份:2023
- 资助金额:
$ 100.34万 - 项目类别:
Role of Hypoxia-Inducible Factors (HIFs) in Respiratory Syncytial Virus Infection
缺氧诱导因子 (HIF) 在呼吸道合胞病毒感染中的作用
- 批准号:
10742170 - 财政年份:2023
- 资助金额:
$ 100.34万 - 项目类别:
Function interactions between mitogen-activated protein kinases (MAPKs) and SARS-CoV-2
丝裂原激活蛋白激酶 (MAPK) 与 SARS-CoV-2 之间的功能相互作用
- 批准号:
10659904 - 财政年份:2023
- 资助金额:
$ 100.34万 - 项目类别:
Multidimensional antibody engineering to enhance the potency and breadth of a betacoronavirus medical countermeasure
多维抗体工程可增强β冠状病毒医学对策的效力和广度
- 批准号:
10699866 - 财政年份:2023
- 资助金额:
$ 100.34万 - 项目类别:
Covid-19 induced worsening of glomerular diseases
Covid-19 导致肾小球疾病恶化
- 批准号:
10655140 - 财政年份:2023
- 资助金额:
$ 100.34万 - 项目类别: